Bronchiolitis natural history: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(12 intermediate revisions by 6 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
The first 2-3 days the patient with bronchiolitis presents with mild upper respiratory symptoms. [[Shortness of breath]], [[wheezing]], persistent prominent [[cough]], [[tachypnea]], chest wall retraction and nasal flaring usually develop between the third and seventh day. Symptoms gradually disappear within the next 2 weeks. Complications are usually observed among patients younger than 2 months of age, premature infants, and patients with other medical conditions ([[congenital heart disease]], chronic [[pulmonary disease]] and [[immunodeficiencies]]). Severity scores can be used to estimate the prognosis.
If left untreated, bronchiolitis may progress to develop mild [[Upper respiratory tract|upper respiratory]] [[symptoms]] including, [[cough]], [[rhinorrhea]] and [[Low-grade fever|low grade fever]] during the first 1-2 days. During third to seventh days of [[infection]], patients develop [[shortness of breath]], [[wheezing]], persistent prominent [[cough]], [[tachypnea]], [[chest wall]] retraction, and [[nasal]] flaring. [[Symptoms]] gradually disappear within the next 2 weeks. [[Complications]] are usually observed in patients younger than 2 months of age, [[Premature birth|premature]] [[infants]], and patients with other medical conditions (including [[congenital heart disease]], chronic [[pulmonary disease]], and [[immunodeficiencies]]). Severity scores can be used to estimate the prognosis.


==Natural History==
==Natural History==
*Patients usually develop symptoms 1 week after the contact with a symptomatic patient.
*Patients usually develop [[symptoms]] after one week of initial contact with a [[symptomatic]] patient.
*The first 2-3 days the patient presents with mild upper respiratory symptoms ([[cough]], [[rhinorrhea]] and low [[fever]]).
*In the first 2-3 days, patients with bronchiolitis present with mild [[Upper respiratory tract|upper respiratory]] [[symptoms]] ([[cough]], [[rhinorrhea]], and [[Low-grade fever|low grade fever]]).
*Acute phase ([[shortness of breath]], [[wheezing]], persistent prominent [[cough]], [[tachypnea]], chest wall retraction and nasal flaring) usually develops between the third and seventh day.
*The acute phase ([[shortness of breath]], [[wheezing]], persistent prominent [[cough]], [[tachypnea]], [[chest wall]] [[retraction]], and [[nasal]] flaring) usually develops between the third and seventh days.
*Symptoms gradually disappear within the next 2 weeks (the [[cough]] may take longer).
**[[Symptoms]] gradually disappear within the next 2 weeks (the [[cough]] may take longer to resolve).
*Bronchiolitis is usually a self-limited [[infection]] which should be eliminated during the next 2 weeks after infection in [[immunocompetent]] patients. However, dissemination of [[Respiratory syncytial virus|virus]] in [[Immunodeficiency overview|immunocompromised]] patients could remain for several months after initial [[infection]].<ref name="pmid192092712">{{cite journal| author=Wright M, Mullett CJ, Piedimonte G| title=Pharmacological management of acute bronchiolitis. | journal=Ther Clin Risk Manag | year= 2008 | volume= 4 | issue= 5 | pages= 895-903 | pmid=19209271 | doi= | pmc=PMC2621418 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19209271  }}</ref>
*Bronchiolitis is usually a self-limited [[infection]] that should be eliminated in two weeks after infection in [[immunocompetent]] patients. However, dissemination of the [[Respiratory syncytial virus|virus]] in [[Immunodeficiency overview|immunocompromised]] patients could remain for several months after initial [[infection]].<ref name="pmid192092712">{{cite journal| author=Wright M, Mullett CJ, Piedimonte G| title=Pharmacological management of acute bronchiolitis. | journal=Ther Clin Risk Manag | year= 2008 | volume= 4 | issue= 5 | pages= 895-903 | pmid=19209271 | doi= | pmc=PMC2621418 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19209271  }}</ref>


==Complications==
==Complications==
Complications are usually observed in patients younger than 2 months, premature infants and patients with associated conditions ([[congenital heart disease]], chronic pulmonary disease and [[immunodeficiencies]]). A list of common complications is listed below:
Complications are usually observed in patients younger than 2 months, [[premature]] [[infants]] and patients with various [[comorbidities]] ([[congenital heart disease]], [[COPD|chronic pulmonary disease]], and [[immunodeficiencies]]). Common complications of bronchiolitis include the following:
*[[Apnea]]: More common in children under 2 months of age and [[premature infants]], it is observed in 3% to 25% of the patients. Several times it appears as the presenting manifestation; however it may be the consequence of previous mild respiratory symptoms.<ref name="Mandell">{{Cite book  | last1 = Mandell | first1 = Gerald L. | last2 = Bennett | first2 = John E. (John Eugene) | last3 = Dolin | first3 = Raphael. | title = Mandell, Douglas, and Bennett's principles and practice of infectious disease | date = 2010 | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | isbn = | pages = }}</ref><ref name="pmid19209271">{{cite journal| author=Wright M, Mullett CJ, Piedimonte G| title=Pharmacological management of acute bronchiolitis. | journal=Ther Clin Risk Manag | year= 2008 | volume= 4 | issue= 5 | pages= 895-903 | pmid=19209271 | doi= | pmc=PMC2621418 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19209271  }} </ref>
*'''[[Apnea]]:'''<ref name="pmid192092712" />
*[[Aspiration]]:
**[[Apnea]] may appear as the presenting manifestation; however, it may be the consequence of previous mild [[respiratory]] infection.
*Recurrent [[wheezing]] episodes: 30%-50% of hospitalized patients with bronchiolitis present recurrent [[wheezing]] episodes, however, episodes usually disappear before [[adolescence]].
**More common in children under 2 months of age and [[premature infants]].
*Associated [[bacterial]] infections: Most common association is with [[urinary tract infections]] (UTI) and [[Otitis media classification#Acute otitis media|acute otitis media]] (AOM), usually not related to the respiratory infection. [[Bacterial]] co-infections appear in 0%-7% of patients with bronchiolitis.
**Observed in 3% to 25% of patients.
*[[Aspiration pneumonia|'''Aspiration pneumonia''']]  
*'''[[wheezing|Recurrent wheezing]] episodes''':  
**Observed in 30%-50% of hospitalized patients with bronchiolitis.
**Episodes usually disappear before [[adolescence]].
*'''Associated [[bacterial infections]]''':  
**The most common [[bacterial infections]] complicating bronchiolitis are [[urinary tract infections]] ([[Urinary tract infection|UTI]]) and [[Otitis media classification#Acute otitis media|acute otitis media]] ([[Otitis media|AOM]]).
**[[Bacterial]] co-infections may appear in up to 7 % of patients with bronchiolitis.


==Prognosis==
==Prognosis==
Prognosis is generally good, as most children show gradual symptomatic improvement within 2 weeks after symptoms begin. Though the rate of hospitalizations is high (71 per 1000 infants for 2003) and has increased in the last 2 decades, the mortality rate is very low (2 deaths per 100 000 livebirths in the U.S. and 1.82 per 100 000 livebirths in the UK).
The [[prognosis]] of bronchiolitis is generally good, as most children show gradual symptomatic improvement within 2 weeks of symptom onset. Albeit the good [[prognosis]], the rate of hospitalization is high (71 per 1000 [[infants]] for 2003) and has increased during the last two decades. The [[mortality rate]] of bronchiolitis is very low (2 deaths per 100,000 live births in the U.S. and 1.82 per 100,000 live births in the UK).<ref name="pmid16860701">{{cite journal| author=Smyth RL, Openshaw PJ| title=Bronchiolitis. | journal=Lancet | year= 2006 | volume= 368 | issue= 9532 | pages= 312-22 | pmid=16860701 | doi=10.1016/S0140-6736(06)69077-6 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16860701  }}</ref>


Clinical scoring systems may help estimate prognosis:
Clinical scoring systems such as the following may help predict the prognosis:
* [[Bronchiolitis severity score]] (BSS)<ref name="pmid1731571">{{cite journal| author=Wang EE, Milner RA, Navas L, Maj H| title=Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. | journal=Am Rev Respir Dis | year= 1992 | volume= 145 | issue= 1 | pages= 106-9 | pmid=1731571 | doi=10.1164/ajrccm/145.1.106 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1731571  }} </ref>
* [[Bronchiolitis severity score]] (BSS)<ref name="pmid1731571">{{cite journal| author=Wang EE, Milner RA, Navas L, Maj H| title=Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. | journal=Am Rev Respir Dis | year= 1992 | volume= 145 | issue= 1 | pages= 106-9 | pmid=1731571 | doi=10.1164/ajrccm/145.1.106 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1731571  }} </ref>
* Court's scale<ref name="pmid4806395">{{cite journal| author=Court SD| title=The definition of acute respiratory illnesses in children. | journal=Postgrad Med J | year= 1973 | volume= 49 | issue= 577 | pages= 771-6 | pmid=4806395 | doi= | pmc=PMC2495839 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4806395  }} </ref>
* Court's scale<ref name="pmid4806395">{{cite journal| author=Court SD| title=The definition of acute respiratory illnesses in children. | journal=Postgrad Med J | year= 1973 | volume= 49 | issue= 577 | pages= 771-6 | pmid=4806395 | doi= | pmc=PMC2495839 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4806395  }} </ref>
Line 33: Line 40:


{{Reflist|2}}
{{Reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Pulmonology]]
[[Category:Pediatrics]]
[[Category:Pediatrics]]
[[Category:Pulmonology]]
[[Category:primary care]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
 
[[Category:Infectious disease]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 20:44, 29 July 2020

Bronchiolitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bronchiolitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Severity Score

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bronchiolitis natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bronchiolitis natural history

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bronchiolitis natural history

CDC on Bronchiolitis natural history

Bronchiolitis natural history in the news

Blogs on Bronchiolitis natural history

Directions to Hospitals Treating Bronchiolitis

Risk calculators and risk factors for Bronchiolitis natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alonso Alvarado, M.D. [2]

Overview

If left untreated, bronchiolitis may progress to develop mild upper respiratory symptoms including, cough, rhinorrhea and low grade fever during the first 1-2 days. During third to seventh days of infection, patients develop shortness of breath, wheezing, persistent prominent cough, tachypnea, chest wall retraction, and nasal flaring. Symptoms gradually disappear within the next 2 weeks. Complications are usually observed in patients younger than 2 months of age, premature infants, and patients with other medical conditions (including congenital heart disease, chronic pulmonary disease, and immunodeficiencies). Severity scores can be used to estimate the prognosis.

Natural History

Complications

Complications are usually observed in patients younger than 2 months, premature infants and patients with various comorbidities (congenital heart disease, chronic pulmonary disease, and immunodeficiencies). Common complications of bronchiolitis include the following:

Prognosis

The prognosis of bronchiolitis is generally good, as most children show gradual symptomatic improvement within 2 weeks of symptom onset. Albeit the good prognosis, the rate of hospitalization is high (71 per 1000 infants for 2003) and has increased during the last two decades. The mortality rate of bronchiolitis is very low (2 deaths per 100,000 live births in the U.S. and 1.82 per 100,000 live births in the UK).[2]

Clinical scoring systems such as the following may help predict the prognosis:

References

  1. 1.0 1.1 Wright M, Mullett CJ, Piedimonte G (2008). "Pharmacological management of acute bronchiolitis". Ther Clin Risk Manag. 4 (5): 895–903. PMC 2621418. PMID 19209271.
  2. Smyth RL, Openshaw PJ (2006). "Bronchiolitis". Lancet. 368 (9532): 312–22. doi:10.1016/S0140-6736(06)69077-6. PMID 16860701.
  3. Wang EE, Milner RA, Navas L, Maj H (1992). "Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections". Am Rev Respir Dis. 145 (1): 106–9. doi:10.1164/ajrccm/145.1.106. PMID 1731571.
  4. Court SD (1973). "The definition of acute respiratory illnesses in children". Postgrad Med J. 49 (577): 771–6. PMC 2495839. PMID 4806395.
  5. Lowell DI, Lister G, Von Koss H, McCarthy P (1987). "Wheezing in infants: the response to epinephrine". Pediatrics. 79 (6): 939–45. PMID 3295741.
  6. Campbell ML (2008). "Psychometric testing of a respiratory distress observation scale". J Palliat Med. 11 (1): 44–50. doi:10.1089/jpm.2007.0090. PMID 18370892.
  7. McCallum GB, Morris PS, Wilson CC, Versteegh LA, Ward LM, Chatfield MD; et al. (2013). "Severity scoring systems: are they internally valid, reliable and predictive of oxygen use in children with acute bronchiolitis?". Pediatr Pulmonol. 48 (8): 797–803. doi:10.1002/ppul.22627. PMID 22949369.

Template:WikiDoc Sources